<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37039676</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>27</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.</ArticleTitle><Pagination><StartPage>e0014423</StartPage><MedlinePgn>e0014423</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00144-23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.00144-23</ELocationID><Abstract><AbstractText>2019 coronavirus disease (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In addition to respiratory illness, COVID-19 patients exhibit neurological symptoms lasting from weeks to months (long COVID). It is unclear whether these neurological manifestations are due to an infection of brain cells. We found that a small fraction of human induced pluripotent stem cell (iPSC)-derived neurons, but not astrocytes, were naturally susceptible to SARS-CoV-2. Based on the inhibitory effect of blocking antibodies, the infection seemed to depend on the receptor angiotensin-converting enzyme 2 (ACE2), despite very low levels of its expression in neurons. The presence of double-stranded RNA in the cytoplasm (the hallmark of viral replication), abundant synthesis of viral late genes localized throughout infected cells, and an increase in the level of viral RNA in the culture medium (viral release) within the first 48&#x2009;h of infection suggested that the infection was productive. Productive entry of SARS-CoV-2 requires the fusion of the viral and cellular membranes, which results in the delivery of the viral genome into the cytoplasm of the target cell. The fusion is triggered by proteolytic cleavage of the viral surface spike protein, which can occur at the plasma membrane or from endosomes or lysosomes. We found that SARS-CoV-2 infection of human neurons was insensitive to nafamostat and camostat, which inhibit cellular serine proteases, including transmembrane serine protease 2 (TMPRSS2). Inhibition of cathepsin L also did not significantly block infection. In contrast, the neuronal infection was blocked by apilimod, an inhibitor of phosphatidyl-inositol 5 kinase (PIK5K), which regulates early to late endosome maturation. <b>IMPORTANCE</b> COVID-19 is a disease caused by the coronavirus SARS-CoV-2. Millions of patients display neurological symptoms, including headache, impairment of memory, seizures, and encephalopathy, as well as anatomical abnormalities, such as changes in brain morphology. SARS-CoV-2 infection of the human brain has been documented, but it is unclear whether the observed neurological symptoms are linked to direct brain infection. The mechanism of virus entry into neurons has also not been characterized. Here, we investigated SARS-CoV-2 infection by using a human iPSC-derived neural cell model and found that a small fraction of cortical-like neurons was naturally susceptible to infection. The productive infection was ACE2 dependent and TMPRSS2 independent. We also found that the virus used the late endosomal and lysosomal pathway for cell entry and that the infection could be blocked by apilimod, an inhibitor of cellular PIK5K.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Kettunen</LastName><ForeName>Pinja</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-3119-4499</Identifier><AffiliationInfo><Affiliation>Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lesnikova</LastName><ForeName>Angelina</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4163-0044</Identifier><AffiliationInfo><Affiliation>Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xe4;s&#xe4;nen</LastName><ForeName>Noora</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojha</LastName><ForeName>Ravi</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7876-4607</Identifier><AffiliationInfo><Affiliation>Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmunen</LastName><ForeName>Leena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laakso</LastName><ForeName>Markku</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehtonen</LastName><ForeName>&#x160;&#xe1;rka</ForeName><Initials>&#x160;</Initials><AffiliationInfo><Affiliation>Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuusisto</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Clinical Research, Kuopio University Hospital, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pietil&#xe4;inen</LastName><ForeName>Olli</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saber</LastName><ForeName>Saber H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joensuu</LastName><ForeName>Merja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vapalahti</LastName><ForeName>Olli P</ForeName><Initials>OP</Initials><AffiliationInfo><Affiliation>Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koistinaho</LastName><ForeName>Jari</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rolova</LastName><ForeName>Taisia</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8869-593X</Identifier><AffiliationInfo><Affiliation>Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balistreri</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-3585-559X</Identifier><AffiliationInfo><Affiliation>Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>GFW2K84S4L</RegistryNumber><NameOfSubstance UI="C504227">apilimod</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.-</RegistryNumber><NameOfSubstance UI="C421305">TMPRSS2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.-</RegistryNumber><NameOfSubstance UI="D010770">Phosphotransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011992" MajorTopicYN="N">Endosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="N">Virus Internalization</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010770" MajorTopicYN="N">Phosphotransferases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PIK5</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">apilimod</Keyword><Keyword MajorTopicYN="N">astrocyte</Keyword><Keyword MajorTopicYN="N">brain</Keyword><Keyword MajorTopicYN="N">central nervous system infections</Keyword><Keyword MajorTopicYN="N">iPSC</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neuron</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>10</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37039676</ArticleId><ArticleId IdType="pmc">PMC10134833</ArticleId><ArticleId IdType="doi">10.1128/jvi.00144-23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xu E, Xie Y, Al-Aly Z. 2022. Long-term neurologic outcomes of COVID-19. Nat Med 28:2406&#x2013;2415. doi:10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, Lange F, Andersson JLR, Griffanti L, Duff E, Jbabdi S, Taschler B, Keating P, Winkler AM, Collins R, Matthews PM, Allen N, Miller KL, Nichols TE, Smith SM. 2022. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604:697&#x2013;707. doi:10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, Sperhake JP, Schr&#xf6;der AS, Edler C, Mushumba H, Fitzek A, Allweiss L, Dandri M, Dottermusch M, Heinemann A, Pfefferle S, Schwabenland M, Sumner MD, Bonn S, Prinz M, Gerloff C, P&#xfc;schel K, Krasemann S, Aepfelbacher M, Glatzel M. 2020. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 19:919&#x2013;929. doi:10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, Laue M, Schneider J, Br&#xfc;nink S, Greuel S, Lehmann M, Hassan O, Aschman T, Schumann E, Chua RL, Conrad C, Eils R, Stenzel W, Windgassen M, R&#xf6;&#xdf;ler L, Goebel HH, Gelderblom HR, Martin H, Nitsche A, Schulz-Schaeffer WJ, Hakroush S, Winkler MS, Tampe B, Scheibe F, K&#xf6;rtv&#xe9;lyessy P, Reinhold D, Siegmund B, K&#xfc;hl AA, Elezkurtaj S, Horst D, Oesterhelweg L, Tsokos M, Ingold-Heppner B, Stadelmann C, Drosten C, Corman VM, Radbruch H, Heppner FL. 2021. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 24:168&#x2013;175. doi:10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, L&#xfc;tgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, Chilla S, Heinemann A, Wanner N, Liu S, Braun F, Lu S, Pfefferle S, Schr&#xf6;der AS, Edler C, Gross O, Glatzel M, Wichmann D, Wiech T, Kluge S, Pueschel K, Aepfelbacher M, Huber TB. 2020. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med 383:590&#x2013;592. doi:10.1056/NEJMc2011400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano GE, Walker JE, Arce R, Glass MJ, Vargas D, Sue LI, Intorcia AJ, Nelson CM, Oliver J, Papa J, Russell A, Suszczewicz KE, Borja CI, Belden C, Goldfarb D, Shprecher D, Atri A, Adler CH, Shill HA, Driver-Dunckley E, Mehta SH, Readhead B, Huentelman MJ, Peters JL, Alevritis E, Bimi C, Mizgerd JP, Reiman EM, Montine TJ, Desforges M, Zehnder JL, Sahoo MK, Zhang H, Solis D, Pinsky BA, Deture M, Dickson DW, Beach TG. 2021. Mapping of SARS-CoV-2 brain invasion and histopathology in COVID-19 disease. medRxiv. doi:10.1101/2021.02.15.21251511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.15.21251511</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, Lu P, Weizman OE, Liu F, Dai Y, Szigeti-Buck K, Yasumoto Y, Wang G, Castaldi C, Heltke J, Ng E, Wheeler J, Alfajaro MM, Levavasseur E, Fontes B, Ravindra NG, van Dijk D, Mane S, Gunel M, Ring A, Jaffar KS, Zhang K, Wilen CB, Horvath TL, Plu I, Haik S, Thomas JL, Louvi A, Farhadian SF, Huttner A, Seilhean D, Renier N, Bilguvar K, Iwasaki A. 2021. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 218. doi:10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F, Carregari VC, Veras FP, Silva LS, Nogueira MH, Antunes ASLM, Vendramini PH, Valen&#xe7;a AGF, Brand&#xe3;o-Teles C, Zuccoli GDS, Reis-de-Oliveira G, Silva-Costa LC, Saia-Cereda VM, Smith BJ, Codo AC, de Souza G, Muraro SP, Parise PL, Toledo-Teixeira DA, de Castro &#xcd;MS, Melo BMS, Almeida GM, Firmino EMS, Paiva IM, Silva BMS, Guimar&#xe3;es RM, Mendes ND, Ludwig RG, Ruiz GP, Knittel TL, Davanzo GG, Gerhardt JA, Rodrigues PB, Forato J, Amorim MR, Brunetti NS, Martini MC, Benatti MN, Batah S, Siyuan L, Jo&#xe3;o RB, Aventurato &#xcd;K, de Brito MR, Alvim MKM, J&#xfa;nior JDS, Dami&#xe3;o LL, de Sousa IMP, da Rocha ED, Gon&#xe7;alves SM, da Silva LHL, et al. 2022. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc Natl Acad Sci USA 119:e2200960119. doi:10.1073/pnas.2200960119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2200960119</ArticleId><ArticleId IdType="pmc">PMC9436354</ArticleId><ArticleId IdType="pubmed">35951647</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung J-Y, Singh M, Yinda CK, Winkler CW, Sun J, Dickey JM, Ylaya K, Ko SH, Platt AP, Burbelo PD, Quezado M, Pittaluga S, Purcell M, Munster VJ, Belinky F, Ramos-Benitez MJ, Boritz EA, Lach IA, Herr DL, Rabin J, Saharia KK, Madathil RJ, Tabatabai A, Soherwardi S, McCurdy MT, Babyak AL, Perez Valencia LJ, Curran SJ, Richert ME, Young WJ, Young SP, Gasmi B, Sampaio De Melo M, Desar S, Tadros S, Nasir N, Jin X, Rajan S, Dikoglu E, Ozkaya N, Smith G, Emanuel ER, Kelsall BL, Olivera JA, Blawas M, Star RA, Hays N, NIH COVID-19 Autopsy Consortium , et al. 2022. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612:758&#x2013;763. doi:10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L, Lendemeijer B, Leijten L, Embregts CWE, Rockx B, Kushner SA, de Vrij FMS, van Riel D. 2021. Replication kinetics, cell tropism, and associated immune responses in SARS-CoV-2- and H5N1 virus-infected human induced pluripotent stem cell-derived neural models. mSphere 6. doi:10.1128/mSphere.00270-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.00270-21</ArticleId><ArticleId IdType="pmc">PMC8265642</ArticleId><ArticleId IdType="pubmed">34160239</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullen CK, Hogberg HT, Bahadirli-Talbott A, Bishai WR, Hartung T, Keuthan C, Looney MM, Pekosz A, Romero JC, Sill&#xe9; FCM, Um P, Smirnova L. 2020. Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2. Alt Anim Exp 37:665&#x2013;671. doi:10.14573/altex.2006111.</Citation><ArticleIdList><ArticleId IdType="doi">10.14573/altex.2006111</ArticleId><ArticleId IdType="pubmed">32591839</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyoo KS, Kim HM, Lee B, Che YH, Kim SJ, Song D, Hwang W, Lee S, Park JH, Na W, Yun SP, Kim YJ. 2022. Direct neuronal infection of SARS-CoV-2 reveals cellular and molecular pathology of chemosensory impairment of COVID-19 patients. Emerg Microbes Infect 11:406&#x2013;411. doi:10.1080/22221751.2021.2024095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.2024095</ArticleId><ArticleId IdType="pmc">PMC8803065</ArticleId><ArticleId IdType="pubmed">34962444</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani A, M&#xfc;ller L, Ostermann PN, Gabriel E, Abida-Islam P, M&#xfc;ller-Schiffmann A, Mariappan A, Goureau O, Gruell H, Walker A, Andr&#xe9;e M, Hauka S, Houwaart T, Dilthey A, Wohlgemuth K, Omran H, Klein F, Wieczorek D, Adams O, Timm J, Korth C, Schaal H, Gopalakrishnan J. 2020. SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J 39:e106230. doi:10.15252/embj.2020106230.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106230</ArticleId><ArticleId IdType="pmc">PMC7560208</ArticleId><ArticleId IdType="pubmed">32876341</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Zhang M, Garcia G, Tian E, Cui Q, Chen X, Sun G, Wang J, Arumugaswami V, Shi Y. 2021. ApoE-isoform-dependent SARS-CoV-2 neurotropism and cellular response. Cell Stem Cell 28:331&#x2013;342.e5. doi:10.1016/j.stem.2020.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.12.018</ArticleId><ArticleId IdType="pmc">PMC7832490</ArticleId><ArticleId IdType="pubmed">33450186</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang BZ, Chu H, Han S, Shuai H, Deng J, Hu Y, Gong HR, Lee ACY, Zou Z, Yau T, Wu W, Hung IFN, Chan JFW, Yuen KY, Huang JD. 2020. SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res 30:928&#x2013;931. doi:10.1038/s41422-020-0390-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0390-x</ArticleId><ArticleId IdType="pmc">PMC7399356</ArticleId><ArticleId IdType="pubmed">32753756</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob F, Pather SR, Huang WK, Zhang F, Wong SZH, Zhou H, Cubitt B, Fan W, Chen CZ, Xu M, Pradhan M, Zhang DY, Zheng W, Bang AG, Song H, Carlos de la Torre J, Li Ming G. 2020. Human pluripotent stem cell-derived neural cells and brain organoids reveal SARS-CoV-2 neurotropism predominates in choroid plexus epithelium. Cell Stem Cell 27:937&#x2013;950.e9. doi:10.1016/j.stem.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7505550</ArticleId><ArticleId IdType="pubmed">33010822</ArticleId></ArticleIdList></Reference><Reference><Citation>Preuss MAR, Faber ML, Tan GS, Bette M, Dietzschold B, Weihe E, Schnell MJ. 2009. Intravenous inoculation of a bat-associated rabies virus causes lethal encephalopathy in mice through invasion of the brain via neurosecretory hypothalamic fibers. PLoS Pathog 5:e1000485. doi:10.1371/journal.ppat.1000485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000485</ArticleId><ArticleId IdType="pmc">PMC2691950</ArticleId><ArticleId IdType="pubmed">19543379</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnell MJ, McGettigan JP, Wirblich C, Papaneri A. 2010. The cell biology of rabies virus: using stealth to reach the brain. Nat Rev Microbiol 8:51&#x2013;61. doi:10.1038/nrmicro2260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2260</ArticleId><ArticleId IdType="pubmed">19946287</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahm T, Rudolph H, Schwerk C, Schroten H, Tenenbaum T. 2016. Neuroinvasion and inflammation in viral central nervous system infections. Mediators Inflamm 2016:1&#x2013;16. doi:10.1155/2016/8562805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/8562805</ArticleId><ArticleId IdType="pmc">PMC4897715</ArticleId><ArticleId IdType="pubmed">27313404</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogovic P, Strle F. 2015. Tick-borne encephalitis: a review of epidemiology, clinical characteristics, and management. World J Clin Cases 3:430. doi:10.12998/wjcc.v3.i5.430.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v3.i5.430</ArticleId><ArticleId IdType="pmc">PMC4419106</ArticleId><ArticleId IdType="pubmed">25984517</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrosa CdS, Goto-Silva L, Temerozo JR, Souza LRQ, Vit&#xf3;ria G, Ornelas IM, Karmirian K, Mendes MA, Gomes IC, Sacramento CQ, Fintelman-Rodrigues N, Cardoso SV, da Silva Gomes Dias S, Salerno JA, Puig-Pijuan T, Oliveira JT, Arag&#xe3;o LGHS, Torquato TCQ, Ver&#xed;ssimo C, Biagi D, Cruvinel EM, Dariolli R, Furtado DR, Borges HL, Bozza PT, Rehen S, Moreno L, Souza T, Guimar&#xe3;es MZP. 2021. Non-permissive SARS-CoV-2 infection in human neurospheres. Stem Cell Res 54:102436. doi:10.1016/j.scr.2021.102436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2021.102436</ArticleId><ArticleId IdType="pmc">PMC8236004</ArticleId><ArticleId IdType="pubmed">34186311</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreutzberger AJB, Sanyal A, Ojha R, Pyle JD, Vapalahti O, Balistreri G, Kirchhausen T. 2021. Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIK5 kinase and TMPRSS2 protease. J Virol 95. doi:10.1128/JVI.00975-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00975-21</ArticleId><ArticleId IdType="pmc">PMC8513479</ArticleId><ArticleId IdType="pubmed">34406858</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch J, Uckeley ZM, Doldan P, Stanifer M, Boulant S, Lozach P-Y. 2021. TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells. EMBO J 40:e107821. doi:10.15252/embj.2021107821.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021107821</ArticleId><ArticleId IdType="pmc">PMC8365257</ArticleId><ArticleId IdType="pubmed">34159616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreutzberger AJB, Sanyal A, Saminathan A, Bloyet L-M, Stumpf S, Liu Z, Ojha R, Patjas MT, Geneid A, Scanavachi G, Doyle CA, Somerville E, Bango R, Cunha CD, di Caprio G, Toppila-Salmi S, M&#xe4;kitie A, Kiessling V, Vapalahti O, Whelan SPJ, Balistreri G, Kirchhausen T. 2022. SARS-CoV-2 requires acidic pH to infect cells. Proc Natl Acad Sci USA 119:e2209514119. doi:10.1073/pnas.2209514119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2209514119</ArticleId><ArticleId IdType="pmc">PMC9499588</ArticleId><ArticleId IdType="pubmed">36048924</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly JL, Simonetti B, Klein K, Chen KE, Williamson MK, Ant&#xf3;n-Pl&#xe1;garo C, Shoemark DK, Sim&#xf3;n-Gracia L, Bauer M, Hollandi R, Greber UF, Horvath P, Sessions RB, Helenius A, Hiscox JA, Teesalu T, Matthews DA, Davidson AD, Collins BM, Cullen PJ, Yamauchi Y. 2020. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370:861&#x2013;865. doi:10.1126/science.abd3072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3072</ArticleId><ArticleId IdType="pmc">PMC7612957</ArticleId><ArticleId IdType="pubmed">33082294</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, van der Meer F, Kallio K, Kaya T, Anastasina M, Smura T, Levanov L, Szirovicza L, Tobi A, Kallio-Kokko H, &#xd6;sterlund P, Joensuu M, Meunier FA, Butcher SJ, Winkler MS, Mollenhauer B, Helenius A, Gokce O, Teesalu T, Hepojoki J, Vapalahti O, Stadelmann C, Balistreri G, Simons M. 2020. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370:856&#x2013;860. doi:10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews MG, Mukhtar T, Eze UC, Simoneau CR, Ross J, Parikshak N, Wang S, Zhou L, Koontz M, Velmeshev D, Siebert C, Gemenes KM, Tabata T, Perez Y, Wang L, Mostajo-Radji MA, de Majo M, Donohue KC, Shin D, Salma J, Pollen AA, Nowakowski TJ, Ullian E, Kumar GR, Winkler EA, Crouch EE, Ott M, Kriegstein AR. 2022. Tropism of SARS-CoV-2 for human cortical astrocytes. Proc Natl Acad Sci USA 199:e2122236119. doi:10.1073/pnas.2122236119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2122236119</ArticleId><ArticleId IdType="pmc">PMC9335272</ArticleId><ArticleId IdType="pubmed">35858406</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M&#xfc;ller MA, Drosten C, P&#xf6;hlmann S. 2020. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271&#x2013;280.e8. doi:10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak W, Huang N, B&#xe9;cavin C, Berg M, Queen R, Litvinukova M, Talavera-L&#xf3;pez C, Maatz H, Reichart D, Sampaziotis F, Worlock KB, Yoshida M, Barnes JL, Banovich NE, Barbry P, Brazma A, Collin J, Desai TJ, Duong TE, Eickelberg O, Falk C, Farzan M, Glass I, Gupta RK, Haniffa M, Horvath P, Hubner N, Hung D, Kaminski N, Krasnow M, Kropski JA, Kuhnemund M, Lako M, Lee H, Leroy S, Linnarson S, Lundeberg J, Meyer KB, Miao Z, Misharin AV, Nawijn MC, Nikolic MZ, Noseda M, Ordovas-Montanes J, Oudit GY, Pe&#x2019;er D, Powell J, Quake S, Rajagopal J, Tata PR, HCA Lung Biological Network , et al. 2020. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med 26:681&#x2013;687. doi:10.1038/s41591-020-0868-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Li MY, Li L, Zhang Y, Wang XS. 2020. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 9:1&#x2013;7. doi:10.1186/s40249-020-00662-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00662-x</ArticleId><ArticleId IdType="pmc">PMC7186534</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Lazartigues E. 2022. Expression of ACE2 in human neurons supports the neuro-invasive potential of COVID-19 virus. Cell Mol Neurobiol 42:305&#x2013;309. doi:10.1007/s10571-020-00915-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-020-00915-1</ArticleId><ArticleId IdType="pmc">PMC7334623</ArticleId><ArticleId IdType="pubmed">32623546</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Wang K, Yu J, Howard D, French L, Chen Z, Wen C, Xu Z. 2021. The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol 11:1860. doi:10.3389/fneur.2020.573095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.573095</ArticleId><ArticleId IdType="pmc">PMC7855591</ArticleId><ArticleId IdType="pubmed">33551947</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. 2022. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol 23:3&#x2013;20. doi:10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuervo NZ, Grandvaux N. 2020. Ace2: evidence of role as entry receptor for SARS-COV-2 and implications in comorbidities. Elife 9:e61390. doi:10.7554/eLife.61390.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.61390</ArticleId><ArticleId IdType="pmc">PMC7652413</ArticleId><ArticleId IdType="pubmed">33164751</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto R, Sakamoto A, Deguchi S, Renxing Y, Sano E, Hotta A, Takahashi K, Yamanaka S, Takayama K. 2021. Dual inhibition of TMPRSS1 and cathepsin B prevents SARS-CoV-2 infection in iPS cells. Mol Ther Nucleic Acids 26:1107&#x2013;1114. doi:10.1016/j.omtn.2021.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2021.10.016</ArticleId><ArticleId IdType="pmc">PMC8527102</ArticleId><ArticleId IdType="pubmed">34692233</ArticleId></ArticleIdList></Reference><Reference><Citation>Bollavaram K, Leeman TH, Lee MW, Kulkarni A, Upshaw SG, Yang J, Song H, Platt MO. 2021. Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V. Protein Sci 30:1131&#x2013;1143. doi:10.1002/pro.4073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.4073</ArticleId><ArticleId IdType="pmc">PMC8138523</ArticleId><ArticleId IdType="pubmed">33786919</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, Xiang Z, Mu Z, Chen X, Chen J, Hu K, Jin Q, Wang J, Qian Z. 2020. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 11:1620. doi:10.1038/s41467-020-15562-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15562-9</ArticleId><ArticleId IdType="pmc">PMC7100515</ArticleId><ArticleId IdType="pubmed">32221306</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson EA, Dyall J, Hoenen T, Barnes AB, Zhou H, Liang JY, Michelotti J, Dewey WH, DeWald LE, Bennett RS, Morris PJ, Guha R, Klumpp-Thomas C, McKnight C, Chen YC, Xu X, Wang A, Hughes E, Martin S, Thomas C, Jahrling PB, Hensley LE, Olinger GG, White JM. 2017. The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection. PLoS Negl Trop Dis 11:e0005540. doi:10.1371/journal.pntd.0005540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0005540</ArticleId><ArticleId IdType="pmc">PMC5402990</ArticleId><ArticleId IdType="pubmed">28403145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang YL, Chou YY, Rothlauf PW, Liu Z, Soh TK, Cureton D, Case JB, Chen RE, Diamond MS, Whelan SPJ, Kirchhausen T. 2020. Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2. Proc Natl Acad Sci USA 117:20803&#x2013;20813. doi:10.1073/pnas.2007837117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2007837117</ArticleId><ArticleId IdType="pmc">PMC7456157</ArticleId><ArticleId IdType="pubmed">32764148</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallroth A, Haucke V. 2018. Phosphoinositide conversion in endocytosis and the endolysosomal system. J Biol Chem 293:1526&#x2013;1535. doi:10.1074/jbc.R117.000629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R117.000629</ArticleId><ArticleId IdType="pmc">PMC5798284</ArticleId><ArticleId IdType="pubmed">29282290</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Hofmann-Winkler H, Smith JC, Kr&#xfc;ger N, Arora P, S&#xf8;rensen LK, S&#xf8;gaard OS, Hasselstr&#xf8;m JB, Winkler M, Hempel T, Raich L, Olsson S, Danov O, Jonigk D, Yamazoe T, Yamatsuta K, Mizuno H, Ludwig S, No&#xe9; F, Kjolby M, Braun A, Sheltzer JM, P&#xf6;hlmann S. 2021. Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity. EBioMedicine 65:103255. doi:10.1016/j.ebiom.2021.103255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103255</ArticleId><ArticleId IdType="pmc">PMC7930809</ArticleId><ArticleId IdType="pubmed">33676899</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi I, Kobayashi E, Asano K, Yoshida M, Nakano H. 1987. UCN-01, a selective inhibitor of protein kinase C from Streptomyces. J Antibiot 4:1782&#x2013;1784. doi:10.7164/antibiotics.40.1782.</Citation><ArticleIdList><ArticleId IdType="doi">10.7164/antibiotics.40.1782</ArticleId><ArticleId IdType="pubmed">3429345</ArticleId></ArticleIdList></Reference><Reference><Citation>Drobny A, Huarcaya SP, Dobert J, Kluge A, Bunk J, Schlothauer T, Zunke F. 2022. The role of lysosomal cathepsins in neurodegeneration: mechanistic insights, diagnostic potential and therapeutic approaches. Biochim Biophys Acta Mol Cell Res 1869:119243. doi:10.1016/j.bbamcr.2022.119243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2022.119243</ArticleId><ArticleId IdType="pubmed">35217144</ArticleId></ArticleIdList></Reference><Reference><Citation>Korzowski A, Weinfurtner N, Mueller S, Breitling J, Goerke S, Schlemmer HP, Ladd ME, Paech D, Bachert P. 2020. Volumetric mapping of intra- and extracellular pH in the human brain using 31 P MRSI at 7T. Magn Reson Med 84:1707&#x2013;1723. doi:10.1002/mrm.28255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.28255</ArticleId><ArticleId IdType="pubmed">32237169</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehtonen &#x160;, H&#xf6;ytyl&#xe4;inen I, Voutilainen J, Sonninen TM, Kuusisto J, Laakso M, H&#xe4;m&#xe4;l&#xe4;inen RH, Oksanen M, Koistinaho J. 2018. Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer&#x2019;s disease. Stem Cell Res 30:96&#x2013;99. doi:10.1016/j.scr.2018.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2018.05.014</ArticleId><ArticleId IdType="pubmed">29807259</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;ntti H, Sitnikova V, Ishchenko Y, Shakirzyanova A, Giudice L, Ugidos IF, G&#xf3;mez-Budia M, Korvenlaita N, Ohtonen S, Belaya I, Fazaludeen F, Mikhailov N, Gotkiewicz M, Ketola K, Lehtonen &#x160;, Koistinaho J, Kanninen KM, Hern&#xe1;ndez D, P&#xe9;bay A, Giugno R, Korhonen P, Giniatullin R, Malm T. 2022. Microglial amyloid beta clearance is driven by PIEZO1 channels. J Neuroinflamm 19:147. doi:10.1186/s12974-022-02486-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02486-y</ArticleId><ArticleId IdType="pmc">PMC9199162</ArticleId><ArticleId IdType="pubmed">35706029</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolova T, Wu YC, Koskuvi M, Voutilainen J, Sonninen TM, Kuusisto J, Laakso M, H&#xe4;m&#xe4;l&#xe4;inen RH, Koistinaho J, Lehtonen &#x160;. 2020. Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer&#x2019;s disease. Stem Cell Res 48:101968. doi:10.1016/j.scr.2020.101968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2020.101968</ArticleId><ArticleId IdType="pubmed">32911327</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme R, Zuccaro E, Ghosh SD, Li C, Sherwood JL, Pietilainen O, Barrett LE, Limone F, Worringer KA, Kommineni S, Zang Y, Cacchiarelli D, Meissner A, Adolfsson R, Haggarty S, Madison J, Muller M, Arlotta P, Fu Z, Feng G, Eggan K. 2018. Combining NGN2 programming with developmental patterning generates human excitatory neurons with NMDAR-mediated synaptic transmission. Cell Rep 23:2509&#x2013;2523. doi:10.1016/j.celrep.2018.04.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.04.066</ArticleId><ArticleId IdType="pmc">PMC6003669</ArticleId><ArticleId IdType="pubmed">29791859</ArticleId></ArticleIdList></Reference><Reference><Citation>Stirling DR, Carpenter AE, Cimini BA. 2021. CellProfiler Analyst 3.0: accessible data exploration and machine learning for image analysis. Bioinformatics 37:3992&#x2013;3994. doi:10.1093/bioinformatics/btab634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btab634</ArticleId><ArticleId IdType="pmc">PMC10186093</ArticleId><ArticleId IdType="pubmed">34478488</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller PY, Janovjak H, Miserez AR, Dobbie Z. 2002. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32:1372&#x2013;1374.</Citation><ArticleIdList><ArticleId IdType="pubmed">12074169</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusanen J, Kareinen L, Levanov L, Mero S, Pakkanen SH, Kantele A, Amanat F, Krammer F, Hedman K, Vapalahti O, Hepojoki J. 2021. A 10-minute &#x201c;mix and read&#x201d; antibody assay for SARS-CoV-2. Viruses 13:143. doi:10.3390/v13020143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020143</ArticleId><ArticleId IdType="pmc">PMC7908974</ArticleId><ArticleId IdType="pubmed">33498157</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>